# Infectious Disease

> Pathogens, epidemiology, transmission genomics, vaccines, environmental drivers, and outbreak science.
> HTML version: https://research.mental-momentum.ai/r/hub/health-longevity-biology/infectious-disease

The study of infectious diseases requires a multi-scale understanding of pathogens, spanning molecular pathophysiology, clinical intervention, and environmental epidemiology. This section of Mental Momentum Research investigates the front lines of outbreak science, analyzing how emerging viral threats spread, how the human immune system defends itself, and how modern biotechnology is reshaping global biosecurity.

A major focal point of our research is the rapid evolution of vaccine platforms. We trace this trajectory from historical eradication efforts to the cutting edge of genetic medicine, analyzing imminent regulatory decisions surrounding mRNA seasonal influenza candidates and their broader implications for oncology and pandemic readiness. At the cellular level, we examine the fundamental mechanics of host defense, including how the innate and adaptive immune systems coordinate long-lasting protection and why conserved physiological responses like fever are vital for optimizing T-cell metabolism.

We also provide deep technical analyses of high-consequence pathogens. Our coverage of filoviruses explores the limits of diagnostics—such as the challenges of detecting Ebola via PCR during early incubation—and evaluates current and investigational prophylaxis strategies. Concurrently, we investigate the rising threat of orthohantaviruses, including the Andes and Seoul variants. This research addresses the molecular pathophysiology of capillary leak syndrome driven by RhoA signaling, critical care standards like advanced hemodynamic monitoring and extra-corporeal membrane oxygenation, and the developmental barriers facing hantavirus DNA and mRNA vaccine candidates.

Finally, we map the environmental and anthropogenic drivers of zoonotic spillover. From climatic shifts and masting cycles in Eurasia to peri-urban land-use changes, ecological disruptions are reshaping the human-wildlife interface. We explore how field researchers deploy portable genomic sequencing and point-of-care diagnostics to manage active transmission hotspots, and we evaluate future biosecurity scenarios to help global systems prepare for both natural and synthetic biological threats.

- [Will the FDA Approve Moderna's mRNA Flu Vaccine in 2026](https://research.mental-momentum.ai/r/will-fda-approve-moderna-s-mrna-flu-2026-egamef) — Read about the FDA's upcoming decision on Moderna's mRNA-1010 flu vaccine (mFLUSIVA), featuring Phase 3 clinical trial results and regulatory updates.
- [What the Flu Decision Means for the Future of mRNA](https://research.mental-momentum.ai/r/what-flu-decision-means-future-mrna-la2bxo) — Discover how the FDA's decision on mRNA seasonal flu vaccines will shape the future of genetic medicine, cancer treatments, and pandemic preparedness.
- [How Your Immune System Responds to a Vaccine](https://research.mental-momentum.ai/r/how-your-immune-system-responds-vaccine-8zcyvd) — Vaccines trigger your innate immune system to cause temporary symptoms while training adaptive T-cells and B-cells to build long-lasting protection.
- [How Smallpox Was Eradicated and What It Teaches Us](https://research.mental-momentum.ai/r/how-smallpox-was-eradicated-what-it-us-kjtiap) — Learn how smallpox was eradicated through global cooperation and ring vaccination, and discover the history of vaccines from variolation to mRNA.
- [How mRNA Flu Vaccines Compare to Traditional Shots](https://research.mental-momentum.ai/r/how-mrna-flu-vaccines-compare-shots-8few4k) — Discover how mRNA flu vaccines compare to traditional flu shots in manufacturing speed, clinical efficacy, and overall immune response.
- [4 Scenarios for the Future of Pandemics and Biosecurity](https://research.mental-momentum.ai/r/4-scenarios-future-pandemics-biosecurity-5o4akw) — Analyze four strategic scenarios for the future of global biosecurity, from zoonotic spillover to synthetic biology and pandemic preparedness.
- [Ebola PCR testing during the incubation period](https://research.mental-momentum.ai/r/ebola-pcr-testing-during-incubation-xeb032) — A negative Ebola PCR test on day 5 of incubation does not clear a traveler, as systemic viremia is typically undetectable prior to symptom onset.
- [Approved and investigational Ebola prophylaxis](https://research.mental-momentum.ai/r/approved-investigational-ebola-yalhrn) — Discover approved and investigational Ebola prevention methods, including the Ervebo and Zabdeno/Mvabea vaccines and post-exposure prophylaxis strategies.
- [Transmission and genomics of 2025-2026 Andes orthohantavirus clusters](https://research.mental-momentum.ai/r/transmission-genomics-2025-2026-andes-0xev1p) — Analyze the 2025-2026 Andes orthohantavirus outbreak, including its environmental drivers, genomic stability, and human-to-human transmission dynamics.
- [Severe hantavirus pulmonary syndrome treatments and critical care](https://research.mental-momentum.ai/r/severe-hantavirus-pulmonary-syndrome-snwmm3) — Learn about Hantavirus Pulmonary Syndrome critical care standards, Andes virus transmission risks, and advanced hemodynamic monitoring using PiCCO and ECMO.
- [Seoul orthohantavirus as a global urban health threat](https://research.mental-momentum.ai/r/seoul-orthohantavirus-as-global-urban-d1gv8u) — Seoul orthohantavirus (SEOV) is a unique global threat spread by urban rats, causing Hemorrhagic Fever with Renal Syndrome via commensal rodent exposure.
- [Molecular Pathophysiology of Hantavirus Capillary Leak in HPS and HFRS](https://research.mental-momentum.ai/r/molecular-pathophysiology-hantavirus-hps-8c8o71) — Learn how hantaviruses cause capillary leak syndrome in HPS and HFRS through RhoA signaling, VE-cadherin disruption, and the kallikrein-kinin system.
- [Land use and peri-urban expansion in hantavirus spillover dynamics](https://research.mental-momentum.ai/r/land-use-peri-urban-expansion-hantavirus-pf4o8r) — Learn how land use changes and peri-urban expansion drive hantavirus spillover by altering rodent reservoir habitats and human-wildlife interfaces.
- [Hantavirus aerosolization and environmental stability in 2026](https://research.mental-momentum.ai/r/hantavirus-aerosolization-environmental-qebpe2) — Explore the mechanics of hantavirus aerosolization and environmental stability, including viral decay rates and rodent-to-human transmission dynamics.
- [Genomic surveillance and diagnostics in rural hantavirus hotspots 2026](https://research.mental-momentum.ai/r/genomic-surveillance-diagnostics-rural-pjaq47) — Explore how portable genomic surveillance and point-of-care diagnostics like RT-LAMP and nanopore sequencing are managing 2026 hantavirus hotspots.
- [Environmental drivers of HFRS expansion in Eurasia](https://research.mental-momentum.ai/r/environmental-drivers-hfrs-expansion-6chl3f) — Explore how climatic shifts, masting cycles, and rodent ecology drive the geographic expansion of Hemorrhagic Fever with Renal Syndrome (HFRS) in Eurasia.
- [2026 Hantavirus mRNA and DNA Vaccine Candidates and Clinical Barriers](https://research.mental-momentum.ai/r/2026-hantavirus-mrna-dna-vaccine-hzncvf) — Explore the 2026 clinical status of hantavirus DNA and mRNA vaccine candidates, including Phase 2 trial results and the impact of immune interference
- [Biological Function of Fever in the Immune System](https://research.mental-momentum.ai/r/biological-function-fever-immune-system-vrb47a) — Fever is a conserved immune strategy that optimizes T cell metabolism and inhibits pathogen replication to enhance host survival during infection.
